CVE-2017-13993
No exploitation reported by the sources we read.
- Published2017-10-05
- WeaknessCWE-427 · CWE-428
Am I affected?
Debian, Ubuntu or Red Hat sometimes backport a fix without changing the upstream version number: such a version reads « to verify », never « affected ».With a domain, we read the version its public headers and pages expose. A distribution build can carry the fix under an older number.
Description
An Uncontrolled Search Path or Element issue was discovered in i-SENS SmartLog Diabetes Management Software, Version 2.4.0 and prior versions. An uncontrolled search path element vulnerability has been identified which could be exploited by placing a specially crafted DLL file in the search path. If the malicious DLL is loaded prior to the valid DLL, an attacker could execute arbitrary code on the system. This vulnerability does not affect the connected blood glucose monitor and would not impact delivery of therapy to the patient.
Timeline
dates in UTC- 2017-10-0501:29CVE publishedNVD
Observed activity
isMalicious corpus · updated 2026-10-23 18:48 UTCBlock these indicators
- Firewall list (EDL, text): https://api.ismalicious.com/edl/cve/CVE-2017-13993?format=txt
- CSV export: https://api.ismalicious.com/edl/cve/CVE-2017-13993?format=csv
- TAXII collection of exploited CVEs
- The EDL and CSV take an API key on the Pro plan.
Versions per branch
NVD| Branch | Affected | Fixed in | Source |
|---|---|---|---|
| 2.4 | ≤ 2.4.0 | no fix published | NVD |
as publishedRanges as NVD and OSV publish them; a distribution’s build can be fixed under an older number.
Distribution builds and vendor advisories
Packages from OSV.dev and products from the vendors' CSAF advisories.
version not verifiedVersions not verified: read as OSV.dev and the vendors publish them, not checked against each vendor's release list.
Vendor advisories
i-SENS, Inc. SmartLog Diabetes Management Software
SmartLog Diabetes Management Software - < 2.4.0
Fix
- Vendor fix CISA ICSMA-17-250-01 · 1 producti-SENS produced an update for the SmartLog Diabetes Management Software, Version 2.4.1, which was released to the i-SENS website on September 1, 2017. It can be found at the following location:
- Vendor fix CISA ICSMA-17-250-01 · 1 producthttp://push.i-sens.com/smartlog2/2.4.1/Install_SmartLog_2.4.1.exe
- Vendor fix CISA ICSMA-17-250-01 · 1 product1.Do not click web links or open unsolicited attachments in email messages.
- Vendor fix CISA ICSMA-17-250-01 · 1 product2.Refer to Recognizing and Avoiding Email Scamsd for more information on avoiding email scams.
- Vendor fix CISA ICSMA-17-250-01 · 1 product3.Refer to Avoiding Social Engineering and Phishing Attackse for more information on social engineering attacks
Advisories and patches
- ics-cert.us-cert.govPatch
Detection
- Nuclei template
- none so far ProjectDiscovery
- Exploit-DB
- no entry Exploit-DB
- Proof-of-concept repositories
- none listed PoC-in-GitHub
Sources
- NVDCVSS 3.07.8read 2026-10-23
- NVDCVSS 2.09.3read 2026-10-23
- CNAweakness (CWE)CWE-428read 2026-10-23
- NVDweakness (CWE)CWE-427read 2026-10-23
- FIRST EPSSEPSS score1.8 %2026-10-22
Technical details
- CVSS v3 Vector
- CVSS:3.0/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
- Published
- 2017-10-05
- Last Modified
- 2026-06-17
- NVD status
- Modified
Frequently asked questions
What is CVE-2017-13993?
Is CVE-2017-13993 actively exploited?
What is the CVSS score for CVE-2017-13993?
Hear about the next vulnerability in your software
Surveillance reads the versions in your stack — a domain, a lockfile or a list — checks each CVE against the ranges its sources publish, and alerts you when one you run is exploited or enters CISA KEV. A version it cannot read stays « version not verified ».
No credit card required · No monthly cap on website lookups · 250 API requests/month
Go further
- Following what attackers exploit right now? The CISA KEV additions of the month, with their patch deadlines.
- Running this software? Vulnerability monitoring alerts you to new vulnerabilities in your products.
Related vulnerabilities
Same product first, then the same vendor advisory and the same publication week.